---
title: "Huaxia Eye: Has begun overseas expansion and will focus on considering acquisition targets primarily in Europe and Asia"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237955221.md"
description: "Huaxia Eye stated during an institutional research that according to the latest strategic layout, the company has also begun its overseas expansion. Considering the recent changes in the international environment, it will focus on acquisition targets primarily in Europe and Asia, including high-quality ophthalmic medical service institutions, and upstream equipment and consumables manufacturers with sustainable R&D capabilities and competitive products. The company is currently recruiting a Director of Overseas Investment and Mergers & Acquisitions"
datetime: "2025-04-29T01:55:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237955221.md)
  - [en](https://longbridge.com/en/news/237955221.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237955221.md)
---

# Huaxia Eye: Has begun overseas expansion and will focus on considering acquisition targets primarily in Europe and Asia

Huaxia Eye stated during an institutional research that according to the latest strategic layout, the company has also begun its overseas expansion. Considering the recent changes in the international environment, it will focus on acquisition targets primarily in Europe and Asia, including high-quality ophthalmic medical service institutions, and upstream equipment and consumables manufacturers with sustainable R&D capabilities and competitive products. The company is currently recruiting a Director of Overseas Investment and Mergers & Acquisitions

### Related Stocks

- [301267.CN](https://longbridge.com/en/quote/301267.CN.md)

## Related News & Research

- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)